Winton Matthew

Winton Matthew is listed in filings as Chief Commercial and Business at CervoMed Inc.. This profile follows SEC Form 4 activity through Feb 13, 2026, including purchase activity. Recent filings connect the profile to CervoMed Inc. (CRVO) and Inozyme Pharma, Inc. (INZY). The current snapshot covers public activity from Oct 3, 2024 to Feb 13, 2026. Reported amounts are shown as $144.0K to $29.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.